The artificial pancreas (AP) is a closed-loop insulin delivery system that regulates blood glucose levels based on continuous glucose monitoring (CGM) data [10, 11], insulin infusion, and other available information [12].CGM technology monitors current blood glucose levels in real-time to assist T1D subjects in controlling blood glucose abnormalities [13–15]. This evidence concerns the gene INS and type 1 diabetes mellitus.